Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best Dow Jones Dividend Stocks that Hedge Funds Love

In this article, we discuss 10 best Dow Jones dividend stocks that hedge funds love. You can skip our detailed discussion on the Dow and dividend stocks, and go directly to read 5 Best Dow Jones Dividend Stocks that Hedge Funds Love

The Dow Jones Industrial Average, or DJIA, is a stock market index of 30 prominent companies listed on the US stock exchanges. DJIA is down 13.13% year-to-date, but this decline is comparatively less severe than the 19.7% drop in the S&P 500, as of the close of October 24. Some of the most prominent Dow stocks include The Coca-Cola Company (NYSE:KO), Walgreens Boots Alliance, Inc. (NASDAQ:WBA), and Intel Corporation (NASDAQ:INTC).

The Dow has maintained its individuality by being the price-weighted index in the US stock market. Though the index tracks the performance of just 30 companies, investing in the Dow provides exposure to some of the best names in the market, providing value to beginner investors. Moreover, these industry-leading companies are also favored because of their dividends and yields. Over the years, the S&P 500 and DJIA have shown a strong correlation, however, their performances have branched off in the past. According to a report by S&P Global, the Dow has slightly outperformed the broader market in the last 30 years ending June 2021. During this period, the S&P 500 delivered a 10.6% return, while DJIA returned 11.16%.

Photo by Dan Dennis on Unsplash

Our Methodology:

Nearly all companies in the Dow Jones Industrial Average are dividend players. For this list, we selected dividend stocks that are popular among hedge funds. We analyzed Insider Monkey’s Q2 2022 database for measuring hedge fund sentiment around each stock.

Best Dow Jones Dividend Stocks that Hedge Funds Love

10. The Procter & Gamble Company (NYSE:PG)

Number of Hedge Fund Holders: 71

The Procter & Gamble Company  is an American multinational consumer goods corporation. The company is one of the best-performing stocks in the consumer staples sector as investors are taking refuge in dividend-paying stocks this year.

The Procter & Gamble Company currently pays a quarterly dividend of $0.9133 per share and has a dividend yield of 2.79%, as of October 26. It is one of the best dividend stocks on our list as it maintains a 66-year track record of consistent dividend growth. Moreover, it has paid dividends consistently for the past 132 years.

In fiscal Q1 2023, The Procter & Gamble Company returned $6.3 billion to shareholders, with dividends amounting to $2.3 billion. The company’s free cash flow productivity stood at 86%.

In October, Barclays raised its price target on The Procter & Gamble Company  to $145 with an Overweight rating on the shares, appreciating the company’s outperformance in its recent quarter.

Of the 895 hedge funds tracked by Insider Monkey, 71 funds owned stakes in The Procter & Gamble Company (NYSE:PG) in Q2 2022, compared with 72 a quarter earlier. These stakes hold a consolidated value of over $5.5 billion. Ray Dalio’s Bridgewater Associates was the company’s leading stakeholder in Q2.

In addition to The Coca-Cola Company (NYSE:KO), Walgreens Boots Alliance, Inc. (NASDAQ:WBA), and Intel Corporation (NASDAQ:INTC), The Procter & Gamble Company (NYSE:PG) is one of the most prominent stocks in DJIA.

9. NIKE, Inc. (NYSE:NKE)

Number of Hedge Fund Holders: 72

NIKE, Inc. (NYSE:NKE) is an Oregon-based multinational manufacturing company that specializes in footwear, apparel, and other accessories. In fiscal Q1 2022, the company returned $480 million to shareholders in dividends, up 11% from the same period last year. It also repurchased shares worth $1 billion during the quarter. At the end of August, the company had roughly $12 billion in cash and cash equivalents and short-term investments.

NIKE, Inc. (NYSE:NKE) pays a quarterly dividend of $0.305 per share. The company has managed to raise its dividends consistently for the past 20 years, which makes it one of the best dividend stocks on our list. As of October 26, the stock has a dividend yield of 1.33%.

In October, Raymond James initiated its coverage on NIKE, Inc. (NYSE:NKE) with an Outperform rating and a $99 price target. The firm sees NKE as one of the most reliable stocks for long-term investment.

As of the close of Q2 2022, 72 hedge funds tracked by Insider Monkey had investments in NIKE, Inc. (NYSE:NKE), up from 67 in the previous quarter. These investments are collectively worth over $3.3 billion.

Leaven Partners mentioned NIKE, Inc. (NYSE:NKE) in its Q3 2022 investor letter. Here is what the firm has to say:

“In our last quarterly letter, I briefly mentioned that the consensus estimates for corporate profits appeared to be a bit too sanguine. I referenced a Reuters article that reported, as of June 17, Wall Street expected S&P 500 earnings to grow by 9.6% in 2022, which was up from 8.8% in April and from 8.4% in January. That tune began to change at the end of July and accelerated in August and September, as major players, such as NIKE (NYSE:NKE), has recently issued profit warnings and/or have withdrawn guidance. In response, Wall Street has altered its outlook: lowering third-quarter profit growth to 4.6%[2] from 7.2% in early August and slashing full-year profit growth to 4.5%.”

8. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 79

Merck & Co., Inc. (NYSE:MRK) was a part of 79 hedge fund portfolios in Q2 2022, according to Insider Monkey’s database. The stakes owned by these hedge funds have a total value of over $6.1 billion. Among these hedge funds, Fisher Asset Management was the company’s leading stakeholder in Q2.

Merck & Co., Inc. (NYSE:MRK) holds an 11-year track record of consistent dividend growth, which makes it one of the best dividend stocks on our list. The company currently pays a quarterly dividend of $0.69 per share and has a dividend yield of 2.82%, as of October 26.

In the second quarter of 2022, Merck & Co., Inc. (NYSE:MRK) reported strong cash generation. The company’s operating cash flow came in at $4.3 billion and its free cash flow was recorded at $3.1 billion. Its worldwide sales amounted to over $1.46 billion, which showed a 28.1% growth from the same period last year.

In October, Barclays raised its price target on Merck & Co., Inc. (NYSE:MRK) to $105 with an Overweight rating on the shares, ahead of the company’s Q3 earnings.

Chartwell Investment Partners mentioned Merck & Co., Inc. (NYSE:MRK) in its Q2 2022 investor letter. Here is what the firm has to say:

“In the Dividend Equity accounts, the three best performers in Q2 includes Merck (NYSE:MRK, 3.6%), up 12.0%. Merck, like other pharma companies, is in a defensive business, but the stock also did well as peak-sales estimates for their flagship drug, Keytruda, have gone up (JPMorgan estimates $32 billion in sales by 2026).”

7. The Home Depot, Inc. (NYSE:HD)

Number of Hedge Fund Holders: 80

Another best dividend stock on our list is The Home Depot, Inc. (NYSE:HD), which is a Georgia-based home improvement company. The company has been growing its dividends for 12 consecutive years and has a five-year dividend CAGR of 16.4%. It currently pays a quarterly dividend of $1.90 per share. As of October 26, the stock’s dividend yield came in at 2.62%. During Q2 2022, The Home Depot, Inc. (NYSE:HD) returned nearly $4 billion to shareholders in dividends.

In October, Cowen initiated its coverage on The Home Depot, Inc. (NYSE:HD) with an Outperform rating and a $350 price target. The firm remained constructive on the company’s sales productivity and share growth. The firm also called HD the best-in-class operator.

The number of hedge funds tracked by Insider Monkey owning stakes in The Home Depot, Inc. (NYSE:HD) grew to 80 in Q2 2022, from 75 in the preceding quarter. These stakes have a total value of over $5.3 billion. Arrowstreet Capital was one of the company’s most prominent stakeholders in Q2.

Diamond Hill Capital mentioned The Home Depot, Inc. (NYSE:HD) in its Q2 2022 investor letter. Here is what the firm had to say:

“The Home Depot, Inc. (NYSE:HD) is a high-quality operator in the home improvement industry. Macroeconomic concerns, particularly the rise in mortgage rates, caused the share price to pull back and trade at a greater discount to our estimate of intrinsic value. We believe Home Depot is well positioned to continue gaining share due to its premium real estate locations, strong operations and recent investments in its supply chain. We like Home Depot’s exposure to the professional customer and believe in its ability to take market share in this segment as we believe home improvement spending has the potential to remain resilient in upcoming years.”

6. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 83

Johnson & Johnson (NYSE:JNJ) specializes in medical devices, pharmaceuticals, consumer products, and other packaged goods. The company has shown strong free cash flow generation over the years, due to which the management has announced the authorization of a buyback program for $5 billion worth of its common stock.

Johnson & Johnson (NYSE:JNJ) has been paying dividends for a long time. In 2022, the company extended its dividend growth streak to 60 years, which makes it one of the best dividend stocks. It currently offers $1.13 per share in quarterly dividends and has a dividend yield of 2.65%, as of October 26.

During the third quarter of 2022, Johnson & Johnson (NYSE:JNJ) returned over $3 billion to shareholders in dividends. Year-to-date, the dividend payments amounted to $8.7 billion. The company’s share buyback program is 40% completed as the company repurchased shares worth over $2 billion during the quarter.

In October, Citigroup maintained its Buy rating on Johnson & Johnson (NYSE:JNJ) with a $198 price target, presenting a positive view of the medical device sector.

Johnson & Johnson (NYSE:JNJ) is a popular dividend stock in the Dow alongside The Coca-Cola Company (NYSE:KO), Walgreens Boots Alliance, Inc. (NASDAQ:WBA), and Intel Corporation (NASDAQ:INTC).

As of the close of Q2 2022, 83 hedge funds tracked by Insider Monkey owned stakes in Johnson & Johnson (NYSE:JNJ), with a total value of over $6.7 billion. In the previous quarter, 83 hedge funds owned stakes in the pharmaceutical company as well, worth over $7.4 billion.

Distillate Capital Partners LLC mentioned Johnson & Johnson (NYSE:JNJ) in its Q2 2022 investor letter. Here is what the firm has to say:

Johnson & Johnson was among the 2 largest trims at around 1% each. Each stock was up 1% in the quarter compared to the 16% price decline for the S&P 500 and the positions were reduced as the valuations became somewhat less appealing, though still attractive enough to warrant inclusion.”

Click to continue reading and see 5 Best Dow Jones Dividend Stocks that Hedge Funds Love

Suggested articles:

Disclosure. None. 10 Best Dow Jones Dividend Stocks that Hedge Funds Love is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…